The Phosphoinositide 3-Kinase Pathway

PHOSPHOINOSITIDE KINASES

Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,382

Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway

Brunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,208

PKB/Akt

Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,068

Regulation of C. elegans Life-Span by Insulinlike Signaling in the Nervous System

Wolkow, C. A., Kimura, K. D., Lee, M. S., & Ruvkun, G. (2000) · Science · doi:10.1126/science.290.5489.147 · Cited by 681

PTEN: a tumour suppressor that functions as a phospholipid phosphatase

Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 599

Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.

Clark, A. S., West, K. A., Streicher, S. A., & Dennis, P. A. (2002) · PubMed · Cited by 589

The lipid phosphatase SHIP2 controls insulin sensitivity

Clément, S., Krause, U., Desmedt, F., Tanti, J., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J. M., Doherty, M., Malaisse, W. J., et al. (2001) · Nature · doi:10.1038/35051094 · Cited by 377

Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival

Liu, D., Xiao-hong, Y., & Songyang, Z. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00733-8 · Cited by 135

Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis

(2009) · Advances in Cancer Research · doi:10.1016/s0065-230x(09)02002-8 · Cited by 620

Hydrogen peroxide – production, fate and role in redox signaling of tumor cells

Lennicke, C., Rahn, J., Lichtenfels, R., Wessjohann, L. A., & Seliger, B. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0118-6 · Cited by 593

Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells

AlGhamdi, K. M., Kumar, A., & Moussa, N. A. (2011) · Lasers in Medical Science · doi:10.1007/s10103-011-0885-2 · Cited by 571

Regulation of the pentose phosphate pathway in cancer

Jiang, P., Du, W., & Wu, M. (2014) · Protein & Cell · doi:10.1007/s13238-014-0082-8 · Cited by 587

The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations

Huang, C., Mandelker, D. L., Schmidt‐Kittler, O., Samuels, Y., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., Gabelli, S. B., & Amzel, L. M. (2007) · Science · doi:10.1126/science.1150799 · Cited by 564

Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size

Easton, R., Cho, H., Roovers, K., Shineman, D. W., Mizrahi, M., Forman, M. S., Lee, V. M. ‐., Szabolcs, M. J., de Jong, R., Oltersdorf, T., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1869-1878.2005 · Cited by 551

Targeting phosphoinositide 3-kinase—Moving towards therapy

Marone, R., Cmiljanović, V., Giese, B., & Wymann, M. P. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.10.003 · Cited by 560

PTEN-deficient cancers depend on PIK3CB

Wee, S., Wiederschain, D., Maira, S., Loo, A. T., Miller, C., deBeaumont, R. S., Stegmeier, F., Yao, Y.-M. M., & Lengauer, C. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0802655105 · Cited by 565

Targeting the PI3K signaling pathway in cancer

Wong, K.-K., Engelman, J. A., & Cantley, L. C. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.002 · Cited by 543

Vascular Cell Senescence: Contribution to Atherosclerosis

Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542

Signalling through Class I PI3Ks in mammalian cells

Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540

Expanding mTOR signaling

Yang, Q., & Guan, K. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 546

Oncogenic Mutations of PIK3CA in Human Cancers

Samuels, Y., & Velculescu, V. E. (2004) · Cell Cycle · doi:10.4161/cc.3.10.1164 · Cited by 551

PTEN

Worby, C. A., & Dixon, J. E. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-082411-113907 · Cited by 558

FOXO Signaling Pathways as Therapeutic Targets in Cancer

Farhan, M., Wang, H., Gaur, U., Little, P. J., Xu, J., & Zheng, W. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20052 · Cited by 548

Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)

Tan, A. C. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13328 · Cited by 549

TLR-signaling Networks

Brown, J. R., Wang, H., Hajishengallis, G., & Martin, M. (2010) · Journal of Dental Research · doi:10.1177/0022034510381264 · Cited by 551

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Serra, V., Scaltriti, M., Prudkin, L., Eichhorn, P. J. A., Ibrahim, Y. H., Chandarlapaty, S., Markman, B., Rodríguez, O., Guzmán, M., Rodriguez, S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.626 · Cited by 541

Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker‐Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 551

Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation

An, J., Yang, H., Zhang, Q., Liu, C., Zhao, J., Zhang, L., & Chen, B. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.024 · Cited by 536

Mammalian Phospholipase C

Kadamur, G., & Ross, E. M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183750 · Cited by 529

AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer

Motoshima, H., Goldstein, B. J., Igata, M., & Araki, E. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108324 · Cited by 543

NGF-Induced Axon Growth Is Mediated by Localized Inactivation of GSK-3β and Functions of the Microtubule Plus End Binding Protein APC

Zhou, F., Zhou, J., Dedhar, S., Wu, Y.-H., & Snider, W. D. (2004) · Neuron · doi:10.1016/j.neuron.2004.05.011 · Cited by 540

Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease

Tolman, K. G., Fonseca, V. A., Dalpiaz, A. S., & Tan, M. H. (2007) · Diabetes Care · doi:10.2337/dc06-1539 · Cited by 533

Issues and progress with protein kinase inhibitors for cancer treatment

Dancey, J. E., & Sausville, E. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1066 · Cited by 526

Recent advances in apoptosis, mitochondria and drug resistance in cancer cells

Indran, I. R., Tufo, G., Pervaiz, S., & Brenner, C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.010 · Cited by 534

Insulin-like Growth Factor-1 (IGF-1) Inversely Regulates Atrophy-induced Genes via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Pathway

Latres, E., Amini, A. R., Amini, A. A., Griffiths, J., Martin, F. J., Wei, Y., Lin, H. C., Yancopoulos, G. D., & Glass, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407517200 · Cited by 538

Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity

Yoon, H., Shaw, J. L., Haigis, M. C., & Greka, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.027 · Cited by 538

Rapid vesicular translocation and insertion of TRP channels

Bezzerides, V. J., Ramsey, I. S., Kotecha, S. A., Greka, A., & Clapham, D. E. (2004) · Nature Cell Biology · doi:10.1038/ncb1150 · Cited by 520

Oncogenic PI3K and its role in cancer

Samuels, Y., & Ericson, K. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198021.99347.b9 · Cited by 519

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas

Lee, J. W., Soung, Y. H., Kim, S. Y., Lee, H. W., Park, W. S., Nam, S. W., Kim, S. H., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2004) · Oncogene · doi:10.1038/sj.onc.1208304 · Cited by 508

“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy

Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 518

Rapid Chemically Induced Changes of PtdIns(4,5)P 2 Gate KCNQ Ion Channels

Suh, B.-C., Inoue, T., Meyer, T., & Hille, B. (2006) · Science · doi:10.1126/science.1131163 · Cited by 505

Mutation of the PIK3CA oncogene in human cancers

Karakas, B., Bachman, K. E., & Park, B. H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602970 · Cited by 505

FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines

Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309523200 · Cited by 505

Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells

Isakoff, S. J., Engelman, J. A., Irie, H. Y., Luo, J., Brachmann, S. M., Pearline, R. V., Cantley, L. C., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2612 · Cited by 505

PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)

Xie, Y., Shi, X., Sheng, K., Han, G., Li, W., Zhao, Q., Jiang, B., Feng, J., Li, J., & Gu, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9713 · Cited by 505

Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials

Fritsch, C. M., Huang, A., Chatenay‐Rivauday, C., Schnell, C., Reddy, A., Liu, M., Kauffmann, A., Guthy, D. A., Erdmann, D., Pover, A. D., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0865 · Cited by 504

Targeting antioxidants for cancer therapy

Glasauer, A., & Chandel, N. S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.017 · Cited by 516

Pathogenesis and Pathophysiology of Pneumococcal Meningitis

Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-11 · Cited by 492

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Furet, P., Guagnano, V., Fairhurst, R. A., Imbach, P. A., Bruce, I., Knapp, M. S., Fritsch, C. M., Blasco, F., Blanz, J., Aichholz, R., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.007 · Cited by 492

The PHD Finger of the Chromatin-Associated Protein ING2 Functions as a Nuclear Phosphoinositide Receptor

Gozani, O., Karuman, P., Jones, D. R., Ivanov, D., Cha, J., Lugovskoy, A. A., Baird, C. L., Zhu, H., Field, S. J., Lessnick, S. L., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00480-x · Cited by 487

The Immunobiology of the Interleukin-12 Family: Room for Discovery

Wojno, E. D. T., Hunter, C. A., & Stumhofer, J. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.011 · Cited by 496

Molecular Mechanisms Underlying the Activation of Mammalian Primordial Follicles

Adhikari, D., & Liu, K. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0048 · Cited by 494

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Kim, S., Dent, R. A., Im, S., Espié, M., Blau, S. H., Tan, A. R., Isakoff, S. J., Oliveira, M., Saura, C., Wongchenko, M. J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30450-3 · Cited by 478

Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

Raught, B., Peiretti, F., Gingras, A., Livingstone, M., Shahbazian, D., Mayeur, G. L., Polakiewicz, R. D., Sonenberg, N., & Hershey, J. W. B. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600193 · Cited by 473

Two insulin receptors determine alternative wing morphs in planthoppers

Xu, H., Xue, J., Lu, B., Zhang, X.-C., Zhuo, J., He, S.-F., Ma, X.-F., Jiang, Y.-Q., Fan, H.-W., Xu, J.-Y., et al. (2015) · Nature · doi:10.1038/nature14286 · Cited by 468

PI3K/Akt/mTOR pathway as a target for cancer therapy

Morgensztern, D., & McLeod, H. L. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000173476.67239.3b · Cited by 473

Survival kinases in ischemic preconditioning and postconditioning

Hausenloy, D. J., & Yellon, D. M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.017 · Cited by 467

Diversity in the Mechanisms of Neuronal Cell Death

Yuan, J., Lipinski, M. M., & Degterev, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00601-9 · Cited by 472

The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease

Oudit, G. Y. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 467

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D., et al. (2004) · Cell · doi:10.1016/j.cell.2004.07.017 · Cited by 465

Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E

Hsieh, A. C., Costa, M., Zollo, O., Davis, C., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 434

Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy

Maddika, S., Ande, S. R., Panigrahi, S., Paranjothy, T., Węglarczyk, K., Zuse, A., ESHRAGHI, M., Manda, K., Wiecheć, E., & Łoś, M. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.01.003 · Cited by 473

Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling

Gewinner, C. A., Wang, Z. C., Richardson, A. L., Teruya‐Feldstein, J., Etemadmoghadam, D., Bowtell, D. D. L., Barretina, J., Lin, W. M., Rameh, L. E., Salmena, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.006 · Cited by 466

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

Hsu, J. L., & Hung, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9649-6 · Cited by 465

Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1

Sofer, A., Lei, K., Johannessen, C. M., & Ellisen, L. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5834-5845.2005 · Cited by 449

Regulated Membrane Trafficking of the Insulin-Responsive Glucose Transporter 4 in Adipocytes

Watson, R. T., Kanzaki, M., & Pessin, J. E. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0011 · Cited by 450

S ELECTIVITY IN N EUROTROPHIN S IGNALING : Theme and Variations

Segal, R. A. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131421 · Cited by 383

PTEN function: how normal cells control it and tumour cells lose it

Leslie, N. R., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 447

mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling

Rodrik-Outmezguine, V. S., Chandarlapaty, S., Pagano, N. C., Poulikakos, P. I., Scaltriti, M., Moskatel, E., Baselga, J., Guichard, S., & Rosen, N. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0085 · Cited by 442

The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation

Pastore, S., Mascia, F., Mariani, V., & Girolomoni, G. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701184 · Cited by 449

Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

Zhao, L., & Vogt, P. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712169105 · Cited by 449

Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors

Schlessinger, J. (2004) · Science · doi:10.1126/science.1105396 · Cited by 438

4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest

Poli, G., Schaur, R. J., Siems, W. G., & Leonarduzzi, G. (2007) · Medicinal Research Reviews · doi:10.1002/med.20117 · Cited by 439

The tyrosine kinase network regulating mast cell activation

Gilfillan, A. M., & Rivera, J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00742.x · Cited by 432

GABAA Receptor Trafficking-Mediated Plasticity of Inhibitory Synapses

Lüscher, B., Fuchs, T. A. E., & Kilpatrick, C. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.024 · Cited by 453

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

Bosch, A., Li, Z., Bergamaschi, A., Ellis, H., Toska, E., Prat, A., Tao, J. J., Spratt, D. E., Viola, N. T., Castel, P., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4442 · Cited by 437

Molecular control of oogenesis

Sánchez, F. G., & Smitz, J. E. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.013 · Cited by 465

Src signaling in cancer invasion

Guarino, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22011 · Cited by 427

Regulation of membrane traffic by phosphoinositide 3-kinases

Lindmo, K., & Stenmark, H. (2006) · Journal of Cell Science · doi:10.1242/jcs.02855 · Cited by 436

Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation

Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K., & Eisel, U. L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311766200 · Cited by 430

PI3K integrates the action of insulin and leptin on hypothalamic neurons

Xu, A. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524301 · Cited by 420

Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer

Koundouros, N., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00160 · Cited by 425

Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer

Miller, T. W., Balko, J. M., & Arteaga, C. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4879 · Cited by 425

Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1

Chen, H.-K., Fernandez-Funez, P., Acevedo, S. F., Lam, Y. C., Kaytor, M. D., Fernandez, M. H., Aitken, A., Skoulakis, E. M. C., Orr, H. T., Botas, J., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00349-0 · Cited by 414

AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

Altomare, D. A., Wang, H. Q., Skele, K. L., Rienzo, A. D., Klein–Szanto, A. J., Godwin, A. K., & Testa, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207721 · Cited by 410

Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit

Miled, N., Yan, Y., Hon, W., Perišić, O., Zvelebil, M., Inbar, Y., Schneidman‐Duhovny, D., Wolfson, H. J., Backer, J., & Williams, R. L. (2007) · Science · doi:10.1126/science.1135394 · Cited by 410

Phosphoinositide 3-kinase signalling – which way to target?

Wymann, M. P., Zvelebil, M., & Laffargue, M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00163-9 · Cited by 410

Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase and Stimulate AKT-Dependent Signaling

Huber, T. B., Hartleben, B., Kim, J. H., Schmidts, M., Schermer, B., Keil, A., Egger, L., Lecha, R. L., Borner, C., Pavenstädt, H., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.4917-4928.2003 · Cited by 408

PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review)

Zhang, Z., Li, Y., Yang, J., Wang, Z., & Du, G. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9375 · Cited by 419

Structural Biology of Shared Cytokine Receptors

Wang, X., Lupardus, P. J., LaPorte, S. L., & García, K. C. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090616 · Cited by 417

2D Nanoclay for Biomedical Applications: Regenerative Medicine, Therapeutic Delivery, and Additive Manufacturing

Gaharwar, A. K., Cross, L., Peak, C. W., Gold, K. A., Carrow, J. K., Brokesh, A. M., & Singh, K. A. (2019) · Advanced Materials · doi:10.1002/adma.201900332 · Cited by 409

PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?

Rommel, C., Camps, M., & Ji, H. (2007) · Nature reviews. Immunology · doi:10.1038/nri2036 · Cited by 405

Akt Blocks Breast Cancer Cell Motility and Invasion through the Transcription Factor NFAT

Yoeli-Lerner, M., Yiu, G. K., Rabinovitz, I., Erhardt, P., Jauliac, S., & Toker, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.033 · Cited by 407

PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond

Fattahi, S., Amjadi‐Moheb, F., Tabaripour, R., Ashrafi, G. H., & Akhavan‐Niaki, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118513 · Cited by 408

Erythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-Reperfusion

Sharples, E. J., Patel, N. S. A., Brown, P. A., Keith, S., Mota‐Filipe, H., Sheaff, M. T., Kieswich, J. E., Allen, D., Harwood, S., Raftery, M., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135059.67385.5d · Cited by 400

Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells

Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 398

Vascular NADPH oxidases: molecular mechanisms of activation

Brandes, R. P., & Kreuzer, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.007 · Cited by 411

N-Glycans in cancer progression

Lau, K. S., & Dennis, J. W. (2008) · Glycobiology · doi:10.1093/glycob/cwn071 · Cited by 390

Hepatitis C virus NS5A: tales of a promiscuous protein

Macdonald, A., & Harris, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80204-0 · Cited by 404

Molecular biology of inflammation and sepsis: A primer*

Cinel, İ., & Opal, S. M. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819267fb · Cited by 400

Dysregulated molecular networks in head and neck carcinogenesis

Molinolo, A., Amornphimoltham, P., SQUARIZE, C. H., CASTILHO, R. M., Patel, V., & Gutkind, J. S. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.011 · Cited by 387

Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism

Pelicano, H., Xu, R., Du, M., Feng, L., Sasaki, R., Carew, J. S., Hu, Y., Ramdas, L., Hu, L., Keating, M. J., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512100 · Cited by 389

Sizing up the heart: development redux in diseasePreprint

Olson, E. N., & Schneider, M. D. (2003) · Genes & Development · doi:10.1101/gad.1110103 · Cited by 386

Gold nanoparticles: Emerging paradigm for targeted drug delivery system

Kumar, A., Zhang, X., & Liang, X. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.002 · Cited by 381

Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

Hu, H., Juvekar, A., Lyssiotis, C. A., Lien, E. C., Albeck, J. G., Oh, D., Varma, G., Hung, Y. P., Ullas, S., Lauring, J. D., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.042 · Cited by 374

Label-free biological and chemical sensors

Hunt, H. K., & Armani, A. M. (2010) · Nanoscale · doi:10.1039/c0nr00201a · Cited by 382

Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers

Sarkar, S. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130134 · Cited by 380

Functional Analysis of PIK3CA Gene Mutations in Human Colorectal Cancer

Ikenoue, T., Kanai, F., Hikiba, Y., Obata, T., Tanaka, Y., Imamura, J., Ohta, M., Jazag, A., Guleng, B., Tateishi, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4114 · Cited by 372

Research Progress on Structure and Function of PI3K

Li, X. (2013) · Journal of Chengdu University

Phosphoinositide 3-Kinase signaling pathway: the key to cell proliferation and death

Peacock, J. G. (2007) · PubMed Central

Phosphatidylinositol-4,5-bisphosphate 3-kinase family in GtoPdb v.2023.1

Uddin, M. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f673/2023.1

Phosphoinositide 3-kinase: A new effector in signal transduction?

Downes, C. P., & Carter, A. N. (1991) · Cellular Signalling · doi:10.1016/0898-6568(91)90027-r · Cited by 160

Protein Kinases as Mediators of Phosphoinositide 3-Kinase Signaling

Toker, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.652 · Cited by 302